Althera Pharmaceuticals, a producer of cardiovascular drugs, is being investigated by the FDA for its Cholesterol oral delivery medicine, Roszet. The FDA’s Office of Prescription Medication Promotion is watching the drug, which combines two common cholesterol therapies into one pill, for promotional statements about its efficacy and risk. The FDA maintains, among other things, that […]

The post FDA Rebukes Althera For Its Cholesterol Medication Claims first appeared on World Pharma Today.